EE alumnus Jonathan S. Maltz (Ph.D. EE '99) is serving as the lead researcher and Chief Scientific Advisor during the clinical trials of HeartSentry, a non-invasive diagnostic tool to measure and monitor cardiovascular health.   HeartSentry is being developed at Lexington Biosciences, a development-stage medical device company in Vancouver, Canada.  It is the product of 15-years of research at U.C. Berkeley.  Maltz has had over 16 years experience designing new devices for assessing vascular function and evaluating these on human subjects.